May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Conjunctival Epithelial Cell Mediators Inhibit Cytokine Release From Activated CD4+ T Cells
Author Affiliations & Notes
  • J. L. Stahl
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Medicine,
  • E. B. Cook
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Medicine,
  • E. A. Schwantes
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Medicine,
  • S. K. Mathur
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Medicine,
  • F. M. Graziano
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Medicine,
  • N. P. Barney
    Univ of Wisconsin-Madison, Madison, Wisconsin
    Ophthalmology and Visual Sciences,
  • Footnotes
    Commercial Relationships  J.L. Stahl, None; E.B. Cook, None; E.A. Schwantes, None; S.K. Mathur, None; F.M. Graziano, None; N.P. Barney, None.
  • Footnotes
    Support  NIH Grant EY012526 and Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2392. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. L. Stahl, E. B. Cook, E. A. Schwantes, S. K. Mathur, F. M. Graziano, N. P. Barney; Conjunctival Epithelial Cell Mediators Inhibit Cytokine Release From Activated CD4+ T Cells. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2392. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : CD4+T cells are the main effector cell driving inflammation in chronic allergic conjunctivitis which is characterized by an activated conjunctival epithelium. Recent studies suggest that the conjunctival epithelium can be activated by Staphylococcus aureus (SA) present on the conjunctiva and lids in the majority of patients with chronic allergic conjunctivitis. The goal of this study was to examine the role of conjunctival epithelial cell mediators in regulation of cytokine release from activated CD4+T cells.

Methods: : Peripheral blood CD4+ T cells were activated with anti-CD3/CD28 coated beads in buffer or supernates from a human conjunctival epithelial cell line (IOBA-NHC, Valladolid, Spain) stimulated with a either SA cell wall extract (CWE) or a combination of TNFα/IL-1β (positive control) or media containing either SA-CWE or a combination of TNFα/IL-1β (direct effect of SA-CWE and cytokines). T cell release of IL-13 and IFNγ were measured by ELISA.

Results: : T cells activated in supernates from SA-CWE stimulated IOBA-NHC cells released markedly less IFNγ and IL-13, compared to T cells activated in buffer. Interestingly, the direct effect of SA-CWE on IFNγ release from CD3/CD28-activated T cells was the opposite, that is, SA-CWE enhanced IFNγ release. T cells activated in supernates from TNFα/IL-1β stimulated IOBA-NHC cells also released less IFNγ and IL-13.

Conclusions: : Mediators released from conjunctival epithelial cells may play an important T cell regulatory role in chronic allergic conjunctivitis.

Keywords: conjunctiva • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×